Loading stock data...

Aarti Pharmalabs Limited

NSE: AARTIPHARM BSE: AARTIPHARM

NSE
909.30 8.95 (0.99%)

Prev Close

900.35

Open Price

904

Volume

266,300

Today Low / High

887.1 / 913.9

52 WK Low / High

551.05 / 949.5

Range

864 - 955

BSE
912.95 12.85 (1.43%)

Prev Close

900.1

Open Price

900.15

Volume

7,960

Today Low / High

887.3 / 913.05

52 WK Low / High

521 / 948.8

Range

867 - 959

The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 909.3 (target range: 864 - 955), reflecting a change of 8.95 (0.99406%). On the BSE, it is listed at 912.95 (target range: 867 - 959), showing a change of 12.85 (1.42762%). Both the NSE and BSE data indicate positive movement, suggesting the stock is on an upward trend. This could be an attractive opportunity for investors looking for growth.

04 Jul 906.00 -0.62%
03 Jul 897.90 0.73%
02 Jul 913.90 -1.75%
01 Jul 898.30 1.60%
30 Jun 863.80 3.07%
27 Jun 880.95 -2.43%
26 Jun 870.75 0.24%
25 Jun 855.00 1.35%
24 Jun 884.00 -3.43%
23 Jun 849.80 2.72%
20 Jun 846.75 0.77%
19 Jun 880.90 -4.36%
18 Jun 863.45 2.01%
17 Jun 874.40 -1.74%
16 Jun 890.00 -1.76%
13 Jun 910.00 -2.68%
12 Jun 921.40 -0.34%
11 Jun 923.50 -0.72%
10 Jun 913.90 1.05%
09 Jun 921.85 -1.16%

Aarti Pharmalabs Limited Graph

Aarti Pharmalabs Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for Aarti Pharmalabs Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 909.30, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 912.95 922.08 829.87 - 1,014.29
931.21 744.97 - 1,117.45
940.34 658.24 - 1,222.44
Bearish Scenario 912.95 903.82 813.44 - 994.20
894.69 715.75 - 1,073.63
885.56 619.89 - 1,151.23

Overview of Aarti Pharmalabs Limited

ISIN

INE0LRU01027

Industry

Drug Manufacturers - Specialty & Generic

Vol.Avg

436,343

Market Cap

81,661,792,620

Last Dividend

3.5

Official Website

Visit Website

IPO Date

2023-01-30

DCF Diff

-138.48

DCF

857

Financial Ratios Every Investor Needs

Stock Dividend of AARTIPHARM

Date Label Adj Dividend Dividend Record Date Payment Date Declaration Date
2025-02-14 February 14, 25 2.5 2.5 2025-02-14 2025-03-07
2024-07-31 July 31, 24 1 1 2024-07-31 2024-09-02
2024-02-16 February 16, 24 2 2 2024-02-19 2024-03-08

Stock Rating Details for AARTIPHARM

Metric Value Recommendation
Overall Rating B+ Neutral
DCF Score 4 Buy
ROE Score 4 Buy
ROA Score 5 Strong Buy
Debt-to-Equity (DE) Score 2 Sell
Price-to-Earnings (PE) Score 2 Sell
Price-to-Book (PB) Score 2 Sell

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2025-03-31 2,115.07 Cr 1,127.88 Cr 987.20 Cr 0.4667 0.00 Cr 0.00 Cr 377.47 Cr 272.40 Cr 30.06 464.37 Cr 0.1288
2024-03-31 1,815.51 Cr 1,424.71 Cr 390.80 Cr 0.2153 8.37 Cr 138.41 Cr 312.81 Cr 216.90 Cr 23.93 390.94 Cr 0.1195
2023-03-31 1,945.23 Cr 1,531.36 Cr 413.87 Cr 0.2128 13.96 Cr 129.69 Cr 279.51 Cr 193.49 Cr 21.35 344.37 Cr 0.0995
2022-03-31 1,192.03 Cr 879.70 Cr 312.33 Cr 0.2620 0.00 Cr 1.51 Cr 164.83 Cr 122.25 Cr 13.49 197.84 Cr 0.1026
2021-03-31 0.00 Cr 0.00 Cr 0.00 Cr 0.0000 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -0.18 0.00 Cr 0.0000

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2025-03-31 8.65 Cr 2,906.41 Cr 916.50 Cr 1,989.9064 Cr 413.12 Cr 404.47 Cr 587.58 Cr 1,410.70 Cr 0.00 Cr 0.00 Cr 29.24 Cr 657.0495 Cr
2024-03-31 23.63 Cr 2,582.11 Cr 825.07 Cr 1,757.0400 Cr 285.25 Cr 261.62 Cr 642.86 Cr 1,105.45 Cr 0.00 Cr 0.00 Cr 36.78 Cr 694.3891 Cr
2023-03-31 12.12 Cr 2,244.02 Cr 685.54 Cr 1,558.4866 Cr 215.31 Cr 203.19 Cr 602.04 Cr 988.57 Cr 0.00 Cr 0.00 Cr -6.03 Cr 600.6234 Cr
2022-03-31 83.27 Cr 2,039.90 Cr 653.42 Cr 1,386.4778 Cr 341.40 Cr 258.13 Cr 475.45 Cr 945.31 Cr 0.00 Cr -1.00 Cr 32.23 Cr 580.6649 Cr
2021-03-31 0.25 Cr 0.25 Cr 0.02 Cr 0.2267 Cr 0.02 Cr -0.23 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.0219 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2025-03-31 331.5615 Cr -413.8977 Cr 65.4350 Cr -70.4759 Cr -16.9012 Cr 6.7337 Cr -443.8784 Cr 272.4048 Cr 93.8005 Cr -31.7191 Cr 55.2790 Cr
2024-03-31 216.3546 Cr -214.5644 Cr 9.7235 Cr 17.5695 Cr 11.5137 Cr 23.6349 Cr -155.6042 Cr 216.9020 Cr 49.9934 Cr -18.1252 Cr -39.6600 Cr
2023-03-31 250.1154 Cr -157.8030 Cr -163.4646 Cr 130.4585 Cr -71.1522 Cr 12.1212 Cr -119.6569 Cr 260.7747 Cr -124.2877 Cr -18.1252 Cr -126.6600 Cr
2022-03-31 -43.7038 Cr -138.7389 Cr 260.3834 Cr -184.8558 Cr 83.0234 Cr 83.2734 Cr -141.1520 Cr 155.3804 Cr 272.3422 Cr 0.0000 Cr -55.9920 Cr
2021-03-31 0.0000 Cr 0.0000 Cr 0.0000 Cr 0.0000 Cr 0.0000 Cr 0.2500 Cr 0.0000 Cr -0.0046 Cr 0.0000 Cr 0.0000 Cr 0.0000 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2025-03-31 563.78 Cr 278.75 Cr 285.03 Cr 0.5056 122.81 Cr 88.34 Cr 9.75 144.54 Cr 0.1567
2024-12-31 537.78 Cr 275.31 Cr 262.47 Cr 0.4881 105.57 Cr 73.99 Cr 8.16 133.64 Cr 0.1376
2024-09-30 458.03 Cr 294.19 Cr 163.84 Cr 0.3577 72.79 Cr 54.62 Cr 6.03 98.16 Cr 0.1193
2024-06-30 555.49 Cr 397.64 Cr 157.85 Cr 0.2842 76.29 Cr 55.45 Cr 6.12 98.68 Cr 0.0998
2024-03-31 468.67 Cr 347.24 Cr 121.43 Cr 0.2591 98.40 Cr 65.25 Cr 7.20 119.55 Cr 0.1392

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2025-03-31 8.65 Cr 47.56 Cr 56.21 Cr 575.40 Cr 587.58 Cr 1,322.17 Cr 1,410.70 Cr 2,906.41 Cr 916.50 Cr
2024-12-31 0.00 Cr 0.00 Cr 99.51 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -1,856.73 Cr
2024-09-30 40.81 Cr 58.16 Cr 99.51 Cr 434.38 Cr 719.80 Cr 1,376.67 Cr 1,228.35 Cr 2,776.51 Cr 919.79 Cr
2024-06-30 -94.32 Cr 188.63 Cr 94.32 Cr 0.00 Cr 0.00 Cr 94.32 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-03-31 23.63 Cr 70.40 Cr 94.45 Cr 519.34 Cr 642.86 Cr 1,345.64 Cr 1,105.45 Cr 2,582.11 Cr 825.07 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2025-03-31 88.34 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-12-31 73.99 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-09-30 54.62 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-06-30 55.45 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-03-31 65.25 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr

Splits History

Date Label Split Ratio
No split history data available.

Similar Stocks: Drug Manufacturers - Specialty & Generic

Company Name Symbol Price Market Cap Volume
Sun Pharmaceutical Industries Limited SUNPHARMA ₹1,674.10 ₹4,016,634,648,000.00 ₹810,840.00
Divi's Laboratories Limited DIVISLAB ₹6,889.50 ₹1,828,948,675,500.00 ₹57,066.00
Torrent Pharmaceuticals Limited TORNTPHARM ₹3,367.00 ₹1,139,544,315,000.00 ₹121,578.00
Dr. Reddy's Laboratories Limited DRREDDY ₹1,308.00 ₹1,088,360,299,920.00 ₹365,638.00
Zydus Lifesciences Limited ZYDUSLIFE ₹995.25 ₹1,001,450,407,500.00 ₹364,100.00
Mankind Pharma Limited MANKIND ₹2,419.00 ₹998,390,870,440.00 ₹314,248.00
Lupin Limited LUPIN ₹1,975.10 ₹902,059,771,600.00 ₹294,678.00
Aurobindo Pharma Limited AUROPHARMA ₹1,186.00 ₹688,831,172,000.00 ₹550,961.00
Alkem Laboratories Limited ALKEM ₹4,870.00 ₹582,281,550,000.00 ₹65,749.00
Glenmark Pharmaceuticals Limited GLENMARK ₹1,872.30 ₹528,364,932,300.00 ₹891,905.00
Laurus Labs Limited LAURUSLABS ₹775.00 ₹417,921,075,000.00 ₹840,385.00
Suven Pharmaceuticals Limited SUVENPHAR ₹1,078.00 ₹412,407,234,624.00 ₹1,177,218.00
Cohance Lifesciences Limited COHANCE ₹1,018.95 ₹389,816,652,802.00 ₹122,471.00
Ipca Laboratories Limited IPCALAB ₹1,466.30 ₹372,006,175,200.00 ₹298,346.00
Ajanta Pharma Limited AJANTPHARM ₹2,658.70 ₹332,103,534,400.00 ₹86,616.00
Wockhardt Limited WOCKPHARMA ₹1,710.90 ₹277,985,321,100.00 ₹324,650.00
Piramal Enterprises Limited PEL ₹1,152.80 ₹261,314,398,400.00 ₹110,079.00
J. B. Chemicals & Pharmaceuticals Limited JBCHEPHARM ₹1,638.90 ₹255,765,095,100.00 ₹229,621.00
Eris Lifesciences Limited ERIS ₹1,742.70 ₹237,350,511,900.00 ₹113,014.00
AstraZeneca Pharma India Limited ASTRAZEN ₹9,112.00 ₹227,800,000,000.00 ₹11,413.00
Alembic Pharmaceuticals Limited APLLTD ₹1,004.40 ₹197,427,877,200.00 ₹89,538.00
Jubilant Pharmova Limited JUBLPHARMA ₹1,198.90 ₹190,961,990,900.00 ₹421,209.00
NATCO Pharma Limited NATCOPHARM ₹973.40 ₹174,345,674,000.00 ₹1,189,397.00
Caplin Point Laboratories Limited CAPLIPOINT ₹2,024.10 ₹153,855,281,970.00 ₹55,029.00
Neuland Laboratories Limited NEULANDLAB ₹11,791.00 ₹151,277,350,900.00 ₹14,602.00
Glenmark Life Sciences Limited GLS ₹1,086.00 ₹133,070,838,000.00 ₹130,938.00
Granules India Limited GRANULES ₹493.85 ₹119,829,739,400.00 ₹256,522.00
Procter & Gamble Health Limited PGHL ₹5,780.00 ₹95,944,532,000.00 ₹5,195.00
Shilpa Medicare Limited SHILPAMED ₹888.15 ₹86,852,987,835.00 ₹29,562.00
FDC Limited FDC ₹514.20 ₹83,716,902,000.00 ₹692,435.00
Aarti Pharmalabs Limited AARTIPHARM ₹909.90 ₹82,468,440,738.00 ₹250,444.00
Strides Pharma Science Limited STAR ₹874.65 ₹80,610,105,555.00 ₹240,574.00
Suven Life Sciences Limited SUVEN ₹267.86 ₹58,413,301,640.00 ₹338,303.00
Sun Pharma Advanced Research Company Limited SPARC ₹157.16 ₹51,001,877,520.00 ₹171,154.00
Innova Captab Limited INNOVACAP ₹851.60 ₹48,732,750,388.00 ₹19,540.00
Sequent Scientific Limited SEQUENT ₹184.54 ₹46,191,284,700.00 ₹237,353.00
Aarti Drugs Limited AARTIDRUGS ₹491.50 ₹44,859,205,000.00 ₹357,856.00
RPG Life Sciences Limited RPGLIFE ₹2,679.80 ₹44,321,212,200.00 ₹79,580.00
Unichem Laboratories Limited UNICHEMLAB ₹599.60 ₹42,215,317,680.00 ₹93,851.00
Hikal Limited HIKAL ₹341.85 ₹42,150,446,850.00 ₹104,423.00
Orchid Pharma Limited ORCHPHARMA ₹740.00 ₹37,532,134,000.00 ₹43,490.00
Morepen Laboratories Limited MOREPENLAB ₹64.45 ₹35,315,635,300.00 ₹2,567,496.00
Gufic Biosciences Limited GUFICBIO ₹344.10 ₹34,505,659,800.00 ₹14,189.00
Solara Active Pharma Sciences Limited SOLARA ₹633.65 ₹30,512,148,450.00 ₹58,137.00
Alembic Limited ALEMBICLTD ₹118.80 ₹30,505,701,481.00 ₹262,043.00
Indoco Remedies Limited INDOCO ₹330.50 ₹30,487,930,950.00 ₹31,866.00
IOL Chemicals and Pharmaceuticals Limited IOLCP ₹94.13 ₹27,629,696,510.00 ₹795,123.00

Key Executives

Senior General Manager of HR & Admin
Mr. Sudhakar Shetty

Gender: male

Year Born:

Head of API Export Regulated and R&D Management
Mr. Sachin Patil

Gender: male

Year Born:

Head of Business Development & Direct Procurement
Mr. Jasmin Mehta

Gender: male

Year Born:

MD & Director
Mr. Narendra Jagannath Salvi

Gender: male

Year Born: 1964

Vice Chairperson & MD
Ms. Hetal Gogri Gala

Gender: female

Year Born: 1975

President of R&D
Dr. B. S. Patravale

Gender: Not Specified

Year Born:

Company Secretary & Compliance Officer
Mr. Jeevan Bhargav Mondkar

Gender: male

Year Born:

Head of Operations & Manufacturing, CDMO & CMO
Mr. G.M. Naidu

Gender: male

Year Born:

Chief Financial Officer
Mr. Piyush P. Lakhani

Gender: male

Year Born:

FAQs about Aarti Pharmalabs Limited

Who is the CEO of the company?

The CEO is Hetal Gogri Gala.

What is the current market price of the stock?

The current price is ₹901.00.

What is the 52-week price range?

The range is ₹551.05-949.5.

What is the market capitalization of the company?

The market capitalization is ₹8,166.18 crores.

What is the dividend yield?

The dividend yield is 0.39%.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is 30.00.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of Aarti Pharmalabs Limited (ISIN: INE0LRU01027) is a leading Drug Manufacturers - Specialty & Generic in India. With a market capitalization of ₹8,166.18 crores and an average daily volume of 436,343 shares, it operates in the Drug Manufacturers - Specialty & Generic. The company last declared a dividend of ₹3.5.